Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.75%67.42B | 6.95%60.33B | 7.19%15.4B | 7.85%15.18B | 6.21%14.89B | 6.55%14.87B | 6.81%56.41B | 8.32%14.37B | 6.23%14.08B | 7.18%14.02B |
| Total premiums earned | 8.46%58.86B | 6.88%54.27B | 7.72%14B | 6.72%13.57B | 6.47%13.37B | 6.56%13.33B | 7.31%50.78B | 6.65%13B | 7.46%12.72B | 7.54%12.56B |
| -Net premiums written | 8.46%58.86B | 6.88%54.27B | 7.72%14B | 6.72%13.57B | 6.47%13.37B | 6.56%13.33B | 7.31%50.78B | 6.65%13B | 7.46%12.72B | 7.54%12.56B |
| Net investment income | -4,760.00%-243M | -150.00%-5M | ---3M | --0 | ---- | ---- | 50.00%-2M | ---- | ---- | ---- |
| Net realized gain loss on investments | 2,934.62%789M | -90.55%26M | -162.76%-91M | --30M | -31.45%85M | -66.67%2M | -8.03%275M | 208.51%145M | --0 | 158.33%124M |
| Total interest income | 27.38%777M | 38.95%610M | 55.34%160M | 55.56%182M | 51.02%148M | -0.83%120M | 38.92%439M | 41.10%103M | 15.84%117M | 36.11%98M |
| Other income expense | 33.34%7.24B | 10.40%5.43B | 18.64%1.33B | 12.50%1.4B | 3.88%1.28B | 7.51%1.42B | 0.68%4.92B | 16.89%1.12B | -2.29%1.24B | -3.36%1.24B |
| Total expenses | 11.17%62.66B | 6.64%56.37B | 9.56%16.15B | -222.34%-15.82B | 244.99%42.85B | 3.34%13.19B | 6.12%52.86B | 6.05%14.74B | 8.06%12.93B | 5.07%12.42B |
| Net policyholder benefits and claims | 9.35%33.35B | 9.16%30.49B | 9.24%7.65B | 7.65%7.76B | 10.05%7.73B | 9.79%7.35B | 9.29%27.93B | 9.90%7B | 9.27%7.21B | 9.49%7.03B |
| Change in insurance liabilities, net of reinsurance | 19.29%3.35B | 5.37%2.8B | 25.46%1.09B | 86.56%1.04B | -86.58%42M | -31.70%627M | -3.24%2.66B | -2.24%872M | 78.85%558M | -39.11%313M |
| Fees and commission expense | 1.95%5.24B | 1.34%5.14B | 1.87%1.31B | 1.04%1.26B | 1.35%1.27B | 1.10%1.29B | -2.43%5.07B | -1.00%1.29B | -3.63%1.25B | -3.38%1.26B |
| Selling and administrative expenses | 13.05%17.86B | 2.90%15.8B | 4.20%3.97B | 2.14%3.96B | 3.57%3.95B | 1.71%3.92B | 4.74%15.35B | 1.90%3.81B | 3.39%3.88B | 7.08%3.81B |
| Other operating expenses | 36.91%2.68B | 14.56%1.96B | 14.46%1.94B | 0.00%6M | 60.00%8M | 20.00%6M | 4.91%1.71B | 4.76%1.69B | 20.00%6M | 0.00%5M |
| Income from associates and other participating interests | --0 | 366.67%8M | ---- | ---- | ---- | ---- | -102.14%-3M | ---- | ---- | ---- |
| Special income (charges) | 6.86%-163M | -45.83%-175M | -184.85%-188M | 106,735.71%29.86B | -497,283.33%-29.84B | 90.00%-2M | 20.00%-120M | 42.11%-66M | -1,300.00%-28M | 73.91%-6M |
| -Less:Restructuring and mergern&acquisition | ---- | ---239M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Other special charges | 2.52%122M | 197.50%119M | 1,042.86%132M | -106,735.71%-29.86B | 497,283.33%29.84B | -90.00%2M | -28.57%40M | -170.00%-14M | 1,300.00%28M | -73.91%6M |
| -Less:Write off | -26.79%41M | -30.00%56M | ---- | ---- | ---- | ---- | -14.89%80M | ---- | ---- | ---- |
| Net non-operating interest income (expenses) | -146.67%-37M | 0.00%-15M | 0.00%-4M | 0.00%-4M | 0.00%-4M | 0.00%-3M | 0.00%-15M | 0.00%-4M | 0.00%-4M | 0.00%-4M |
| -Non-operating interest expense | 146.67%37M | 0.00%15M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%3M | 0.00%15M | 0.00%4M | 0.00%4M | 0.00%4M |
| Income before tax | 13.18%4.75B | 18.43%4.2B | 1.42%929M | -3.10%688M | 18.97%1.39B | 58.64%1.19B | 18.30%3.54B | 64.45%916M | -18.58%710M | 31.79%1.17B |
| Income tax | 6.00%1.56B | 16.61%1.47B | -20.39%242M | 14.16%403M | 27.09%441M | 50.00%381M | 42.47%1.26B | -14.37%304M | 44.67%353M | 289.89%347M |
| Net income | 17.04%3.19B | 19.48%2.73B | 12.60%688M | -20.17%285M | 15.38%945M | 63.18%811M | 8.14%2.28B | 200.99%611M | -43.15%357M | 3.02%819M |
| Net income continuous operations | 17.04%3.19B | 19.43%2.73B | 12.25%687M | -20.17%285M | 15.53%945M | 63.05%812M | 8.19%2.29B | 202.97%612M | -43.15%357M | 2.89%818M |
| Noncontrolling interests | -51M | 0 | ||||||||
| Net income attributable to the company | 18.94%3.25B | 19.48%2.73B | 12.60%688M | -20.17%285M | 15.38%945M | 63.18%811M | 8.14%2.28B | 200.99%611M | -43.15%357M | 3.02%819M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 18.94%3.25B | 19.48%2.73B | 12.60%688M | -20.17%285M | 15.38%945M | 63.18%811M | 8.14%2.28B | 200.99%611M | -43.15%357M | 3.02%819M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 23.40%41.98 | 20.98%34.02 | 14.76%8.63 | -17.27%3.64 | 16.67%11.76 | 63.24%9.99 | 8.20%28.12 | 202.01%7.52 | -43.08%4.4 | 3.07%10.08 |
| Diluted earnings per share | 23.40%41.98 | 20.98%34.02 | 14.76%8.63 | -18.59%3.5768 | 16.67%11.76 | 63.24%9.99 | 8.20%28.12 | 202.01%7.52 | -43.15%4.3937 | 3.06%10.0797 |
| Dividend per share | 54.55%8.5 | 37.50%5.5 | 37.50%5.5 | 0 | 0 | 0 | 60.00%4 | 60.00%4 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |